Vaxart, Inc. announced the retirement of its Chairman, Michael J. Finney, Ph.D., from the Board of Directors and Science and Technology Committee.
Michael J. Finney will step down from his position effective September 30, 2025, after a distinguished tenure of service at Vaxart.
The Board of Directors will convene to discuss leadership changes, composition, and governance issues in the upcoming month.
Chairman Retirement
Michael J. Finney, Ph.D., is retiring from his role as Chairman of Vaxart's Board of Directors and Science and Technology Committee.
Effective Date
The retirement of Michael J. Finney will take effect on September 30, 2025, marking the end of his service at Vaxart.
Board Meeting
The Board of Directors will hold a meeting this month to address leadership, governance, and stockholder feedback.
- Michael J. Finney's retirement will lead to changes in leadership and governance within Vaxart.
- The Company aims to continue its scientific progress following the retirement of the Chairman.
- Stockholder feedback will influence decisions related to Board leadership and composition.
Vaxart expresses gratitude for Michael J. Finney's contributions and leadership during his tenure as Chairman. The Company looks forward to advancing its oral pill vaccine platform and scientific endeavors.